| Trial Identifier: | D0817R00010 |
| Sponsor: | AstraZeneca |
| Start Date: | February 2021 |
| Primary Completion Date: | July 2025 |
| Study Completion Date: | July 2025 |
| Condition: | Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| South Korea | Bucheon, South Korea |
| South Korea | Changwon, South Korea |
| South Korea | Goyang, South Korea |
| South Korea | Gunpo, South Korea |
| South Korea | Hwaseong, South Korea |
| South Korea | Ilsan, South Korea |
| South Korea | Jeonju, South Korea |
| South Korea | Seongnam, South Korea |
| South Korea | Suwon, South Korea |
| South Korea | Uijeongbu, South Korea |
| South Korea | Yangsan, South Korea |
| South Korea | Yongin, South Korea |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company